• Chia-Hung Lin, Ching-Han Lin, Mu-Chi Chung, Chi-Sheng Hung, Fen-Yu Tseng, Leay Kiaw Er, Jia-Yin HouCharlesCCardiovascular Center, MacKay Memorial Hospital, Taipei, Taiwan., Yen-Hung Lin, Vin-Cent Wu, Hao-Min Cheng, Hsien-Li Kao, Kwan-Dun Wu, and Tai-Shuan Lai.
• Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
• J Formos Med Assoc. 2024 Mar 1; 123 Suppl 2: S98S103S98-S103.

AbstractThe aldosterone-to-renin ratio (ARR) is the standard screening test for primary aldosteronism (PA). Because of the poor reproducibility of the ARR, repeat testing is recommended if the result is not compatible with the clinical condition. Various methods to measure renin are used in different hospitals in Taiwan, and the ARR cutoff values also differ among laboratories. The Task Force of Taiwan PA recommend using plasma renin activity (PRA) to calculate ARR instead of direct renin concentration (DRC) unless PRA is unavailable, because PRA is widely used in international guidelines and most studies.Copyright © 2023 Formosan Medical Association. Published by Elsevier B.V. All rights reserved.

14 keywords...

hide…